BCAT:NYE-BlackRock Capital Allocation Trust (USD)

COMMON STOCK | |

Last Closing

USD 15.36

Change

0.00 (0.00)%

Market Cap

USD 1.67B

Volume

0.31M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-22 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TBB AT&T Inc

N/A

USD 147.42B
PRS Prudential Financial Inc

N/A

USD 44.13B
ALL-PB The Allstate Corporation

N/A

USD 34.20B
SOJC Southern Co

N/A

USD 22.29B
AIZN Assurant Inc

N/A

USD 9.38B
RZB Reinsurance Group of America I..

N/A

USD 8.75B
PCG-PA Pacific Gas and Electric Compa..

N/A

USD 5.95B
UNMA Unum Group

N/A

USD 5.48B
PCG-PB Pacific Gas and Electric Compa..

N/A

USD 5.30B
PCG-PD Pacific Gas and Electric Compa..

N/A

USD 4.76B

ETFs Containing BCAT

YYY Amplify High Income ETF 3.13 % 0.50 %

N/A

USD 0.56B
PCEF Invesco CEF Income Compos.. 0.00 % 0.50 %

N/A

USD 0.84B

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.39% N/A N/A 49% F
Dividend Return 1.90% N/A N/A 85% B
Total Return 3.29% N/A N/A 64% D
Trailing 12 Months  
Capital Gain -1.73% N/A N/A 28% F
Dividend Return 15.32% N/A N/A 98% N/A
Total Return 13.59% N/A N/A 64% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -5.85% N/A N/A 10% F
Dividend Return 0.43% N/A N/A 23% F
Total Return 6.28% N/A N/A 89% A-
Risk Return Profile  
Volatility (Standard Deviation) 15.28% N/A N/A 66% D+
Risk Adjusted Return 2.83% N/A N/A 22% F
Market Capitalization 1.67B N/A N/A 64% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike